Company intelligence / Profile preview
Grand Medical Group
Luzern, Lucerne, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
Over 75 branded pharma, OTC, and supplement products and 320+ market registrations across Europe, Asia, Africa; strong commercial footprint in key therapeutic sectors
- Therapeutic areas
- ImmunologyEndocrinologyMen's HealthInfectious DiseasesGastroenterologyCardiovascularNeurologyWomen's Health
- Modalities
- Small moleculeBiologicHerbal compoundSynthetic compound
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Contract manufacturingStrategic alliances
Beyond the preview
Go deeper on Grand Medical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grand Medical Group.